Laurence Zitvoge, Guido Kroemer
Boosting the T cells that mediate anticancer immune responses is a therapeutic goal. But T cells do not work alone - B cells and the antibodies they produce can both trigger and suppress the response. See Letters p.94 & p.99
© 2001-2025 Fundación Dialnet · Todos los derechos reservados